CANCER TREATMENT PATHWAYS AND GUIDELINES

AIM Cancer Treatment Pathways

AIM Cancer Treatment Pathways are cancer treatment regimens intended to support quality cancer care and reduce unneeded variation in care and cost. They are developed through a rigorous process of integrating evidence-based literature with physician practice guidelines.

OPEN THE CANCER TREATMENT PATHWAYS

 

AIM Clinical Appropriateness Guidelines for Febrile Neutropenia Risk

AIM Clinical Appropriateness Guidelines for Febrile Neutropenia Risk are developed through a rigorous process integrating evidence-based literature with expert review.  The Guidelines address determination of febrile neutropenia risk to guide the use of white blood cell growth factors for oncology drug treatment regimens in adults.

OPEN THE GUIDELINES FOR FEBRILE NEUTROPENIA RISK

 

Trouble viewing the pathways or guidelines?

To open our pathways or guidelines, your computer needs Adobe Reader, free and trusted software that allows you to view PDFs.

GET ADOBE READER